
11 - 50 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Spyre Therapeutics is a biopharmaceutical company focused on developing therapies for Inflammatory Bowel Disease (IBD). The company is committed to creating best-in-class antibodies, rational therapeutic combinations, and employing precision immunology approaches to enhance treatment efficacy and convenience for IBD patients. With a team experienced in developing and commercializing treatments across various diseases, Spyre Therapeutics is dedicated to improving treatment options and outcomes for patients through advanced research in immunology. The company fosters a collaborative and innovative environment to achieve its mission of providing promising new treatment options for IBD.
🕒 Yesterday
Senior Director of Clinical Development contributing to clinical strategy for rheumatology at Spyre Therapeutics. Playing a key role in executing global clinical development programs and regulatory activities.
🕒 Yesterday
Director, Clinical Scientist at Spyre Therapeutics designing and executing clinical trials for novel therapies in rheumatic diseases. Collaborating across functions to ensure robust study designs and high-quality data generation.
🕒 July 3
Senior Director of Biostatistics leading statistical activities in clinical trials for biotechnology innovations. Driving strategic input and fostering collaboration across multidisciplinary study teams.
🕒 July 1
Senior Manager in GCP Quality Assurance at Spyre Therapeutics responsible for supporting Clinical Quality Assurance efforts and ensuring compliance with global regulations.
🕒 May 27
Associate Director overseeing structural and functional characterization in biotechnology for inflammatory bowel disease and rheumatic diseases. Leading teams in analytical development and regulatory submissions.